All of the synovial joints, especially the weight-bearing joints that support the body, contain viscoelastic hyaluronic acid.
This substance has lubricating and anti-shock properties. A reduction in stress on the cartilage allows it to regenerate and thus reduce the progression of osteoarthritis.
Hyaflex is recommended for the treatment of joint pain or stiffness resulting from degenerative or post-traumatic osteoarthritis in the knee as a replacement or in combination with traditional non-pharmacological therapy or analgesic treatment.
The hyaluronic acid contained in Hyaflex is a natural polysaccharide derived from microorganisms (Streptococcus zooepidemicus) and then purified.
Hyaflex is injected into the joint cavity to restore the synovial fluid.
The hyaluronic acid contained in Hyaflex has an ideal molecular weight for easy injection (650 - 1200 kDa).
Single-use glass syringe containing 2,5 ml of product in a sterile package.
2.5 ml of Hyaflex contains 25 mg of sodium hyaluronate dissolved in physiological saline solution (pH between 6.8 and 7.8).
* Maximum recommended weekly dose
Medical device • CE2797
STERILE INJECTABLE MEDICAL DEVICE • Available in pharmacies - Hyaflex must be administered by a physician.
1Hyaflex is a medical device recommended for the treatment of pain from arthritis in the joints in patients who have not responded adequately to conservative non-pharmacological treatment and simple analgesics such as acetaminophen.
For healthy cartilage*.
Bioglucosamine MAX helps ensure the functionality of cartilage*.
NC2 helps ensure cartilage function*.
USA300 contains substances derived from soya.
A unique combination for healthy cartilage*.
HYAFLEX FORTE is recommended for the treatment of joint pain.
Mobilityl helps keep joints supple*.
A unique combination for joint mobility and tendons*.
Mobilityl Max helps maintain joint flexibility*.
For a complete management of joint mobility* !
No result was found for your search